prgn-3006
pgen therapeutics
['prgn-3006', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
 in the dose expansion phase, patients can receive repeat dosing of prgn-3006. there is no requirement for additional lymphodepletion in repeat dose patients due to the demonstrated ability of prgn-3006 to expand in the absence of lymphodepletion. $prgn #ash22 #aml 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold